Labcorp Holdings Valuation
Is LH * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LH * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LH * (MX$4101) is trading below our estimate of fair value (MX$10688.98)
Significantly Below Fair Value: LH * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LH *?
Key metric: As LH * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is LH *'s PE Ratio? | |
|---|---|
| PE Ratio | 45.8x |
| Earnings | US$435.50m |
| Market Cap | US$19.97b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.1x |
| Enterprise Value/EBITDA | 15.7x |
| PEG Ratio | 2.2x |
Price to Earnings Ratio vs Peers
How does LH *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 20.9x | ||
DGX Quest Diagnostics | 21.6x | 11.7% | US$18.1b |
DVA DaVita | 16.6x | 4.3% | US$13.7b |
FME Fresenius Medical Care | 18.7x | 19.3% | €12.3b |
SHL Sonic Healthcare | 26.7x | 11.0% | AU$13.8b |
LH * Labcorp Holdings | 45.8x | 20.6% | Mex$20.0b |
Price-To-Earnings vs Peers: LH * is expensive based on its Price-To-Earnings Ratio (45.8x) compared to the peer average (21x).
Price to Earnings Ratio vs Industry
How does LH *'s PE Ratio compare vs other companies in the Global Healthcare Industry?
| 12 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 12 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: LH * is expensive based on its Price-To-Earnings Ratio (45.8x) compared to the Global Healthcare industry average (20.9x).
Price to Earnings Ratio vs Fair Ratio
What is LH *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 45.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate LH *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.